Heparin-induced thrombocytopenia

From WikiMD.org
Jump to navigation Jump to search

Heparin-induced thrombocytopenia (pronunciation: heh-puh-rin in-doost throm-boh-sy-toh-PEE-nee-uh) is a complication of heparin therapy. It is a prothrombotic disorder, meaning it can cause the formation of abnormal blood clots in the body.

Etymology

The term "Heparin-induced thrombocytopenia" is derived from the following components: "Heparin", a type of anticoagulant medication; "induced", meaning caused by; and "thrombocytopenia", a condition characterized by abnormally low levels of platelets in the blood.

Definition

Heparin-induced thrombocytopenia (HIT) is a serious side effect of heparin treatment. It occurs when the body's immune system reacts to heparin and forms antibodies. These antibodies activate platelets, which can lead to the formation of blood clots, a condition known as thrombosis.

Symptoms

Symptoms of HIT may include unexpected blood clotting, a decrease in platelet count, skin changes at the site of heparin injection, and in severe cases, damage to organs due to blood clots.

Diagnosis

Diagnosis of HIT involves a combination of clinical assessment and laboratory testing. The 4Ts score is a clinical scoring system used to estimate the probability of HIT. Laboratory tests include the serotonin release assay (SRA) and the enzyme-linked immunosorbent assay (ELISA).

Treatment

Treatment of HIT involves discontinuing heparin and starting alternative anticoagulant therapy. Direct thrombin inhibitors such as argatroban and bivalirudin are commonly used. In some cases, a procedure called plasma exchange may be performed.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski